EMA and NICE Appraisal Processes for Cancer Drugs : Current Status and Uncertainties
| dc.contributor.author | Dickson, Rumona | |
| dc.contributor.author | Boland, Angela | |
| dc.contributor.author | Duarte, Rui | |
| dc.contributor.author | Kotas, Eleanor | |
| dc.contributor.author | Woolacott, Nerys | |
| dc.contributor.author | Hodgson, Robert | |
| dc.contributor.author | Riemsma, Rob | |
| dc.contributor.author | Grimm, Sabine | |
| dc.contributor.author | Ramaekers, Bram | |
| dc.contributor.author | Joore, Manuela | |
| dc.contributor.author | Büyükkaramikli, Nasuh | |
| dc.contributor.author | Kaltenthaler, Eva | |
| dc.contributor.author | Stevenson, Matt | |
| dc.contributor.author | Pandor, Abdullah | |
| dc.contributor.author | Edwards, Steve | |
| dc.contributor.author | Hoyle, Martin | |
| dc.contributor.author | Shepherd, Jonathan | |
| dc.contributor.author | Armoiry, Xavier | |
| dc.contributor.author | Brazzelli, Miriam | |
| dc.contributor.institution | University of Aberdeen.Aberdeen Centre for Evaluation | en |
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
| dc.date.accessioned | 2019-02-06T15:50:08Z | |
| dc.date.available | 2019-02-06T15:50:08Z | |
| dc.date.issued | 2018-08 | |
| dc.description | The Evidence Review Group members that contributed to this editorial are funded by the UK NIHR HTA Programme. The views and opinions expressed are those of the authors and do not necessarily reflect those of the UK Department of Health and the NIHR. | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 4 | |
| dc.format.extent | 418311 | |
| dc.identifier | 141971311 | |
| dc.identifier | 673e322a-75b8-4c4e-8dbf-b9da5c88a148 | |
| dc.identifier | 29808296 | |
| dc.identifier | 85047664700 | |
| dc.identifier.citation | Dickson, R, Boland, A, Duarte, R, Kotas, E, Woolacott, N, Hodgson, R, Riemsma, R, Grimm, S, Ramaekers, B, Joore, M, Büyükkaramikli, N, Kaltenthaler, E, Stevenson, M, Pandor, A, Edwards, S, Hoyle, M, Shepherd, J, Armoiry, X & Brazzelli, M 2018, 'EMA and NICE Appraisal Processes for Cancer Drugs : Current Status and Uncertainties', Applied Health Economics and Health Policy, vol. 16, no. 4, pp. 429-432. https://doi.org/10.1007/s40258-018-0393-7 | en |
| dc.identifier.doi | 10.1007/s40258-018-0393-7 | |
| dc.identifier.iss | 4 | en |
| dc.identifier.other | PubMedCentral: PMC6028888 | |
| dc.identifier.uri | http://hdl.handle.net/2164/11875 | |
| dc.identifier.vol | 16 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Applied Health Economics and Health Policy | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | H Social Sciences | en |
| dc.subject.lcc | H | en |
| dc.title | EMA and NICE Appraisal Processes for Cancer Drugs : Current Status and Uncertainties | en |
| dc.type | Journal article | en |
